Hot Features
프리미엄
Zevra Therapeutics Inc (ZVRA)
NASDAQ
브라질 증권 거래소, NASDAQ, NYSE, AMEX, LSE 등 주요 거래소에서의 다양한 실시간 주식 시세를 모니터링합니다.
Zevra Therapeutics, Inc. is a rare disease therapeutics company. The Company is engaged in creating therapies for diseases with limited or no treatment options. The Company has a diverse portfolio of products and product candidates, which includes a combination of both a clinical-stage pipeline and ... Zevra Therapeutics, Inc. is a rare disease therapeutics company. The Company is engaged in creating therapies for diseases with limited or no treatment options. The Company has a diverse portfolio of products and product candidates, which includes a combination of both a clinical-stage pipeline and commercial stage assets. It employs its LAT platform technology to create a portfolio of approved products. Its product candidates include Arimoclomol, KP1077IH, KP1077N and AZSTARYS. Arimoclomol is an orally delivered, investigational product candidate being developed for Niemann-Pick disease type C (NPC). KP1077 is the Company's lead clinical development product candidate, which is being developed as a treatment for idiopathic hypersomnia (IH) and narcolepsy. KP1077 is comprised solely of serdexmethylphenidate (SDX), the Company's prodrug of d-methylphenidate (d-MPH). AZSTARYS is a prodrug for the treatment of ADHD in patients aged six years or older. 더 보기
New clinical efficacy and safety data for arimoclomol as a possible treatment for Niemann-Pick disease type C, including from long-term and real-world settings, demonstrate clinically meaningful...
CELEBRATION, Fla., Aug. 29, 2024 (GLOBE NEWSWIRE) -- Zevra Therapeutics, Inc. (NasdaqGS: ZVRA) (Zevra, or the Company), a rare disease therapeutics company, today announced that Neil F...
FDA advisory committee voted favorably that the data support arimoclomol as effective treatment for patients with NPC; PDUFA date of September 21, 2024 Pro forma June 30, 2024, cash, cash...
CELEBRATION, Fla., Aug. 08, 2024 (GLOBE NEWSWIRE) -- Zevra Therapeutics, Inc. (Nasdaq: ZVRA), a rare disease therapeutics company (“Zevra”), today announced the pricing of an underwritten public...
CELEBRATION, Fla., Aug. 08, 2024 (GLOBE NEWSWIRE) -- Zevra Therapeutics, Inc. (Nasdaq: ZVRA), a rare disease therapeutics company (“Zevra”), today announced the commencement of a proposed...
| 기간 | 변동 | 변동 % | 시가 | 고가 | 저가 | 평균 일일 거래량 | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | 0.715 | 10.0210231254 | 7.135 | 8.12 | 6.63 | 578029 | 7.32025123 | CS |
| 4 | 3.46 | 78.8154897494 | 4.39 | 8.4399 | 4.2 | 834726 | 6.78338259 | CS |
| 12 | 1.65 | 26.6129032258 | 6.2 | 8.4399 | 4.2 | 496046 | 6.37533003 | CS |
| 26 | 2.46 | 45.6400742115 | 5.39 | 8.4399 | 3.89 | 359524 | 6.11071333 | CS |
| 52 | 2.2 | 38.9380530973 | 5.65 | 8.4399 | 3.89 | 320785 | 5.86984151 | CS |
| 156 | 2.2 | 38.9380530973 | 5.65 | 8.4399 | 3.89 | 320785 | 5.86984151 | CS |
| 260 | 0 | 0 | 0 | 8.12 | 0 | 0 | 0 | CS |
janice shell
3 분 전
crazy horse 0
4 분 전
blackcat
4 분 전
janice shell
4 분 전
1vman
5 분 전
LVerstee
5 분 전
Donotunderstand
5 분 전
srinsocal
5 분 전
janice shell
6 분 전
jjjjjjjj
7 분 전
blackcat
7 분 전
ddls
8 분 전
janice shell
9 분 전
crazy horse 0
9 분 전
janice shell
10 분 전
MiamiGent
11 분 전
zab
12 분 전
blackcat
13 분 전
JohnnyMakeBucks
13 분 전
Eli's Gone
13 분 전
Scotttrader80
14 분 전
janice shell
15 분 전
prislea
15 분 전
